DHL Express Singapore has entered into a strategic partnership with Life Science Incubator to support capability buildin...
Ascletis Pharma has dosed the first participant in its global Phase III clinical programme evaluating ASC30, an investig...
Singapore is expanding subsidised access to Roche’s Columvi, or glofitamab, for eligible patients with relapsed or...
Singapore has become the first ASEAN country to provide government subsidies for eligible patients receiving vutrisiran ...
Taiwan-based Formosa Pharmaceuticals has submitted a Clinical Trial Application to European regulators for a pivotal stu...
Shanghai-based DualityBio has entered a global collaboration and licensing agreement with Genentech to develop next-gene...
Fosun Pharma continued to strengthen its innovation-led growth strategy in the first half of 2026, supported by increasi...
Alebund Pharmaceuticals has reported progress across its renal disease portfolio, including completion of enrolment in a...
Antengene has received approval in Australia to initiate a Phase I clinical study of ATG-201, its investigational CD19/C...
Australian oncology biotechnology company Kazia Therapeutics has reported a 100% clinical benefit rate among the first s...
Australian cellular health company Longevity Life Sciences has entered into a multi-year strategic partnership with Mits...
Cell Therapies has manufactured and released the first clinical dose for the KOALA trial, a first-in-human study evaluat...
Akeso has received clinical trial clearance from China’s Center for Drug Evaluation for AK157D1, a next-generation...
Nanjing Leads Biolabs has announced that China’s Center for Drug Evaluation has accepted the New Drug Application ...
CureGene has dosed the first participant in an Australian Phase I clinical trial of CG-0416, an investigational oral liv...
CStone Pharmaceuticals has received approval from China’s National Medical Products Administration to initiate cli...
Telix Pharmaceuticals has reported continued progress across its radiopharmaceutical imaging and therapeutic pipeline du...
Brii Biosciences has advanced its internally developed mRNA therapeutic cancer vaccine BRII-5395 into clinical evaluatio...
Brown University Health and Arcamyra Therapeutics are preparing to launch a Phase I clinical trial of ACM-CpG in patient...
CanSino Biologics has announced that China’s National Medical Products Administration has accepted the New Drug Ap...
Everest Medicines has announced that China’s National Medical Products Administration has accepted the Biologics L...
The 2026 CDISC China Interchange has brought clinical research data specialists and industry stakeholders together in Sh...
Ascletis Pharma has initiated two Phase I studies in the United States evaluating investigational once-monthly injectabl...
A Phase III clinical trial has found that adding high-dose vitamin D3 to chemotherapy and bevacizumab does not improve p...
Shanghai Ark Biopharmaceutical, or ArkBio, has completed dosing across all healthy-volunteer cohorts in an Australian Ph...
